UPEXI Updates Business Address & Phone in 8-K Filing

TL;DR

**UPEXI just updated its official contact info in an 8-K, keeping records current.**

AI Summary

UPEXI, INC. filed an 8-K on January 4, 2024, to update its corporate information, including its business address to 3030 North Rocky Point Drive, Suite 420, Tampa, Florida 33607, and its telephone number to (727) 287-2800. This filing primarily serves to ensure public records are current, which is important for investors as it confirms the company's operational transparency and accessibility. For shareholders, accurate contact information means they can reach the company with questions or concerns, reflecting good corporate governance.

Why It Matters

This filing ensures that UPEXI's public contact information is current, which is crucial for investor communication and regulatory compliance. Accurate contact details reflect operational transparency and accessibility for shareholders.

Risk Assessment

Risk Level: low — This filing is purely administrative, updating contact information, and does not indicate any operational or financial risks.

Analyst Insight

Investors should note the updated contact information for UPEXI, INC. for any future correspondence or due diligence. This administrative update doesn't warrant immediate trading action but reinforces the company's compliance with disclosure requirements.

Key Numbers

• January 4, 2024 — Date of Report (The date of the earliest event reported in the 8-K filing.)
• (727) 287-2800 — Registrant's telephone number (The updated contact number for UPEXI, INC.)
• 3030 North Rocky Point Drive, Suite 420, Tampa, Florida 33607 — Address of Principal Executive Offices (The updated physical location of UPEXI, INC.'s main offices.)
• $0.001 — Par value of Common Stock (The stated par value per share of UPEXI, INC.'s Common Stock.)

Key Players & Entities

• UPEXI, INC. (company) — the registrant filing the 8-K
• January 4, 2024 (date) — date of earliest event reported
• 3030 North Rocky Point Drive, Suite 420, Tampa, Florida 33607 (location) — new principal executive offices address
• (727) 287-2800 (dollar_amount) — new registrant's telephone number
• Nevada (location) — state of incorporation
• 001-40535 (dollar_amount) — SEC file number
• UPXI (company) — trading symbol for Common Stock
• $0.001 (dollar_amount) — par value of Common Stock

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 UPXI NASDAQ Indicate by check mar

Filing Documents

• upxi_8k.htm (8-K) — 25KB
• upxi_ex991.htm (EX-99.1) — 6KB
• 0001477932-24-000053.txt ( ) — 156KB
• upxi-20240104.xsd (EX-101.SCH) — 6KB
• upxi-20240104_lab.xml (EX-101.LAB) — 15KB
• upxi-20240104_cal.xml (EX-101.CAL) — 1KB
• upxi-20240104_pre.xml (EX-101.PRE) — 9KB
• upxi-20240104_def.xml (EX-101.DEF) — 2KB
• upxi_8k_htm.xml (XML) — 4KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.

01 Other Events

Item 8.01 Other Events. On January 4, 2024, the Company issued a press release announcing an invitation to participate at the iAccess Alpha 2024 Buyside Best Ideas Summit hosted virtually on January 9-10, 2024. Upexi's Chief Executive Officer, Allan Marshall, is scheduled to present at 11:00 a.m. EST on January 9th and host one-on-one meetings on January 10th. A copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. The information in Item 7.01 and Item 8.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any of the Company's filings under the Securities Act, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference to this Report in such filing. Section 9 – Financial Statements and Exhibits

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Exhibit Description 99.1 Press Release of Upexi, Inc., dated January 4, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UPEXI, INC. Dated: January 5, 2024 /s/ Andrew J. Norstrud Name: Andrew J. Norstrud Title: Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR